1. Home
  2. ANGH vs BCTX Comparison

ANGH vs BCTX Comparison

Compare ANGH & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anghami Inc.

ANGH

Anghami Inc.

N/A

Current Price

$3.44

Market Cap

33.8M

ML Signal

N/A

BCTX

BriaCell Therapeutics Corp.

N/A

Current Price

$3.58

Market Cap

36.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANGH
BCTX
Founded
2012
2014
Country
United Arab Emirates
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
36.6M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
ANGH
BCTX
Price
$3.44
$3.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.6K
★ 62.6K
Earning Date
12-29-2026
12-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 88.79
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$251.30
N/A
Revenue Next Year
$26.67
$250.50
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$2.60
52 Week High
$7.89
$13.09

Technical Indicators

Market Signals
Indicator
ANGH
BCTX
Relative Strength Index (RSI) 48.26 50.00
Support Level $3.12 $3.50
Resistance Level $3.89 $3.74
Average True Range (ATR) 0.20 0.29
MACD 0.00 0.06
Stochastic Oscillator 54.75 53.98

Price Performance

Historical Comparison
ANGH
BCTX

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. The Group's three reportable segments: Revenue from subscriptions, Revenue from advertisement, and Revenue from live events. It generates the majority of its revenue from subscriptions segment, which is comes from subscription fees. The advertisement revenue segment generated through the sale of advertising across the Group's content. Revenues from live events are generated from the sale of tickets, food and beverage & sponsorship. It derives maximum revenue from KSA.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: